Kent hospice raises £40,000 with annual bluebell walk
A hospice in Kent has raised £40,000 from its annual bluebell walk.Heart of Kent Hospice welcomed 550 walkers of all ages on its six-mile (9.6km) walk which started at Harrietsham Village Hall and went through the North Downs.The Aylesford-based charity said the total could increase to about £45,000 once the final sponsorship money is collected.Richard Neville, who took part in the walk, said: "We got out in the lovely Kent countryside to support a charity really close to our hearts and to remember Dad, who loved taking part in previous years and who the hospice provided an immense amount of care for."
He added: "It is such a privilege to be able to fundraise to give more families the care and support we had when Dad was a patient."Maisie Bass, the charity's events manager, said: "Thank you to everyone who took part, fundraised and donated to ensure Heart of Kent Hospice can continue giving compassionate end-of-life care to those who need it most."The charity is already encouraging people to join its 2026 bluebell walk.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
33 minutes ago
- BBC News
Frances Norris death: Bracknell care home boss struck off
A director of a care company fined £1m following the death of a dementia patient who was put into a scalding bath has been struck off the nursing Jeebun was a director of Aster Healthcare Limited, which was fined for corporate manslaughter after Frances Norris, 93, died three days after the incident at the Birdsgrove Nursing Home in Bracknell in Nursing and Midwifery Council (NMC) panel found Mr Jeebun showed "a long-term disregard for patient safety" and that the incident was part of "a pattern of serious failings".Police investigated Mr Jeebun but he was not prosecuted after Aster Healthcare Limited admitted corporate manslaughter in 2021. The home shut in 2016. Mrs Norris was in the bath for "several minutes" before staff realised the water was too hot. When she was taken to hospital, it was found 12% of her body had been covered in serious Jeebun was the most senior person in the home responsible for health and safety, a report found. The NMC said "several official organisations" raised concerns about its thermostatic mixing valves (TMVs) "on more than one occasion".But it found Mr Jeebun set a £200 spending limit for staff that could not be exceeded without his panel found the risk of residents being scalded was "entirely foreseeable" and had been "aggravated by [his] cost-cutting at the expense of safety". 'Absence of accountability' It said he tried replace the TMV in the bath where Mrs Norris was scalded before investigators could seize Jeebun also told a junior colleague to fabricate records of water temperatures or face losing his job, the NMC March 2020, while still under police investigation, Mr Jeebun wrote to the NMC in an effort to have his nursing registration cancelled NMC said that showed his "lack of insight and absence of accountability".In 2021 home manager Elisabeth West and carer Noel Maida were given suspended prison sentences over Ms Norris's death after admitting they failed to discharge their duties correctly. Ms Norris's family previously paid tribute to her as a "warm, generous and kind-hearted" woman. You can follow BBC Berkshire on Facebook, X (Twitter), or Instagram.
BBC News
an hour ago
- BBC News
'I will fade away without vital pancreas medication', says Hartley man
A Kent man who has had three-quarters of his pancreas removed says he will "fade away" without a medication that there has been a nationwide shortage of since Elcombe, from Hartley, takes Creon three times a day, after major surgery three years ago left him no longer able to create enough enzymes to break down food. As it stands, he has three and a half weeks worth of tablets left, having only had one prescription filled this said: "You need it to survive, without it [Creon] your body can't break down the as important as insulin is to a diabetic." The nationwide shortage, which the Department of Health and Social Care (DHSC) says is a "European-wide" supply issue, has forced the 63-year-old and his wife to spend time travelling to different pharmacies in a bid to get the said: "I know it sounds dramatic, but without it you will just fade very scary."Mr Elcombe also had a third of his stomach removed during the operation, alongside his gallbladder and part of his small said he had a hugely depleted supply of Creon despite reducing his intake from the intended 24 tablets to just eight a limits what he can consume because the 63-year-old can't eat without it. He added: "You're never 100% after your operation. The fatigue you get is chronic; not eating makes it worse."Mr Elcombe said the shortage - which has become worse this year - was not expected to lift until December 2026.A spokesperson for the DHSC said: "We know how frustrating and distressing medicine supply issues can be for patients and the clinicians caring for them."The European-wide supply issues with Creon are caused by a limited availability of raw ingredients and manufacturing capacity constraints."We are working closely with industry and the NHS to mitigate the impact on patients and resolve the issues as quickly as possible."
The Guardian
an hour ago
- The Guardian
Contraception warning over weight-loss drugs after dozens of pregnancies
Women using weight-loss drugs have been urged to use effective contraception after dozens have reported becoming pregnant while taking the medication. The Medicines and Healthcare products Regulatory Agency (MHRA) has issued its first alert to the UK public regarding contraception and weight-loss medications after it received 40 reports relating to pregnancies while using drugs such as Ozempic, Wegovy and Mounjaro. Ozempic and Wegovy, which both contain semaglutide, work by mimicking a hormone called GLP-1 that triggers an increase in the production of insulin, slows the rate at which food is digested in the stomach and reduces appetite. Mounjaro, which contains the active ingredient tirzepatide, acts on a second hormone involved in appetite and blood sugar control. Although these have been referred to as 'weight-loss injections', not all are authorised for weight loss. The MHRA said Mounjaro may reduce the effectiveness of oral contraceptives such as the pill in people who are overweight, and that women taking the medication should use barrier contraceptives such as condoms. It said it had received 26 pregnancy-related reports for Mounjaro. Last year the Guardian reported that the popularity of weight-loss drugs had resulted in an unexpected baby boom. The Facebook group 'I got pregnant on Ozempic' had more than 750 members at the time. The MHRA said there had been eight reports relating to pregnancy in those taking semaglutide and nine reports for liraglutide, which is found in another weight-loss drug, Saxenda. Although it is not necessary for women in the reports to say if the pregnancy was unintentional, two of these reports said the pregnancy was such. The watchdog also said these drugs must not be taken during pregnancy, while trying to get pregnant or while breastfeeding, as there was 'not enough safety data to know whether taking the medicine could cause harm to the baby'. It said that in some instances women should continue using contraception for up to two months between stopping the medicine and trying to get pregnant. Dr Channa Jayasena, a consultant in reproductive endocrinology and andrology at Imperial College healthcare NHS trust, said: 'GLP-1 drugs copy the natural hormones made in the gut which make you feel full. This makes them powerful treatments to help women lose weight. 'Obesity reduces fertility in women. So, women with obesity taking GLP-1 drugs are more likely to get pregnant than before they lost weight. 'In addition, we think that the absorption of oral contraceptive pills may be reduced with GLP-1 drugs which slow down emptying of the stomach, though more research is needed to confirm this. 'The guidance produced by the MHRA is sensible, since it highlights that women could accidentally get pregnant when taking GLP-1 drugs. 'We don't know how harmful GLP-1 drugs are during pregnancy; however, we know that other forms of weight loss like weight-loss surgery can increase chances of a miscarriage. So women are advised to do all they can to prevent pregnancy while taking GLP-1 drugs.' Dr Alison Cave, the MHRA's chief safety officer, said: 'Skinny jabs are medicines licensed to treat specific medical conditions and should not be used as aesthetic or cosmetic treatments. They are not a quick fix to lose weight and have not been assessed to be safe when used in this way. 'Our guidance offers patients a one-stop shop for our up-to-date advice on how to use these powerful medicines safely. 'This guidance should not be used as a substitute to reading the patient information leaflet or having a conversation with a healthcare professional as part of the prescribing process.'
